Use of Thalidomide in Patients With Arachnoiditis

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This pilot study will evaluate whether thalidomide decreases pain in patients with arachnoiditis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborator: Celgene Corporation
• Treatments: Thalidomide

Criteria

Inclusion Criteria:

• Radiographically confirmed Arachnoiditis

• Involvement of the lower limb(s)

Exclusion Criteria:

• Subjects with baseline peripheral neuropathy to include diabetic neuropathy and other metabolic or toxic neuropathies.